Cargando…
Potential of Anti-MUC1 Antibodies as a Targeted Therapy for Gastrointestinal Cancers
Gastrointestinal cancers (GI) account for 26% of cancer incidences globally and 35% of all cancer-related deaths. The main challenge is to target cancer specific antigens. Mucins are heavily O-glycosylated proteins overexpressed in different cancers. The transmembrane glycoprotein MUC1 is the most l...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712407/ https://www.ncbi.nlm.nih.gov/pubmed/33167508 http://dx.doi.org/10.3390/vaccines8040659 |